Despite the challenges in studying recurrent implantation failure, progress is currently being made in therapeutic options to help those who suffer from recurrent implantation failure. Three of the most promising therapeutic options for recurrent implantation failure include immune therapies such as peripheral blood mononuclear cells, platelet rich plasma and subcutaneous granulocyte-colony stimulating factor.
Keywords: Recurrent implantation failure; granulocyte colony stimulating factor; peripheral blood mononuclear cells; platelet rich plasma.
Copyright © 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.